GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_32550/2025

BioNTech Innovative Manufacturing Services GmbH, BioNTech Manufacturing GmbH, BioNTech SE, Promosome LLC, BioNTech Manufacturing Marburg GmbH, BioNTech Europe GmbH, Pfizer, Inc., Pfizer Manufacturing Belgium NV, Pfizer AB, Pfizer SAS v. Promosome LLC, The Scripps Research Institute

Datum
2025-07-15
Kammer
Munich (DE) Local Division
Verfahrensart
Application RoP262A
Sprache
EN

Metadaten

Fall-IDORD_32550-2025-7f252b105564
Aktenzeichen
RegisterzeichenORD_32550/2025
EntscheidungsreferenzORD_32550/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 Order of the Court of First Instance of the Unified Patent Court issued on 15 July 2025 APPLICANTS (DEFENDANTS IN THE MAIN PROCEEDINGS, COUNTERCLAIMANTS): 1. BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany, 2. BioNTech Manufacturing GmbH, An der Goldgrube 12, 55131 Mainz, Germany, 3. BioNTech Manufacturing Marburg GmbH, Emil-von-Bering-Straße 76, 35041 Marburg, Germany, 4. BioNTech Innovative Manufacturing Services GmbH, Vollmersbachstraße 66, 55743 Idar- Oberstein, Germany, 5. BioNTech Europe GmbH, An der Goldgrube 12, c/o BioNTech SE, 55131 Mainz, Germany, represented by: Christine Kanz of HOYNG ROKH MONEGIER, Steinstrasse 20 - 40212 – Duesseldorf, DE. (for Defendants 1-5). 6. Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs-Sint-Amands, Belgium, 7. Pfizer SAS, 23-25 Ave ...